Cargando…

White matter microstructural damage in early treated phenylketonuric patients

BACKGROUND: Despite dietary intervention, individuals with early treated phenylketonuria (ETPKU) could present neurocognitive deficits and white matter (WM) abnormalities. The aim of the present study was to evaluate the microstructural integrity of WM pathways across the whole brain in a cohort of...

Descripción completa

Detalles Bibliográficos
Autores principales: González, María Julieta, Polo, Mónica Rebollo, Ripollés, Pablo, Gassió, Rosa, Ormazabal, Aída, Sierra, Cristina, Roura, Roser Colomé, Artuch, Rafael, Campistol, Jaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203973/
https://www.ncbi.nlm.nih.gov/pubmed/30367646
http://dx.doi.org/10.1186/s13023-018-0912-5
_version_ 1783365970323046400
author González, María Julieta
Polo, Mónica Rebollo
Ripollés, Pablo
Gassió, Rosa
Ormazabal, Aída
Sierra, Cristina
Roura, Roser Colomé
Artuch, Rafael
Campistol, Jaume
author_facet González, María Julieta
Polo, Mónica Rebollo
Ripollés, Pablo
Gassió, Rosa
Ormazabal, Aída
Sierra, Cristina
Roura, Roser Colomé
Artuch, Rafael
Campistol, Jaume
author_sort González, María Julieta
collection PubMed
description BACKGROUND: Despite dietary intervention, individuals with early treated phenylketonuria (ETPKU) could present neurocognitive deficits and white matter (WM) abnormalities. The aim of the present study was to evaluate the microstructural integrity of WM pathways across the whole brain in a cohort of paediatric ETPKU patients compared with healthy controls (HCs), by collecting DTI-MRI (diffusion tensor magnetic resonance imaging) data and diffusion values (mean diffusivity (MD), radial diffusivity (RD) and fractional anisotropy (FA)). METHODS: DTI-MRI data and diffusion values (MD, RD, FA) from WM tracts across the whole brain were analized using Tract Based Spatial Statistics (TBSS), in 15 paediatrics TPKU patients (median age: 12 years) and compared with 11 HCs. Areas showing abnormal values in the patient group were correlated (Pearson) with age, lifetime Phe values, last year median and mean Phe, concurrent Phe values in plasma, urine neurotransmitters status biomarkers, and with a processing speed task. RESULTS: ETPKU showed bilaterally decreased MD values compared with HCs in the body and splenium of the corpus callosum, superior longitudinal fasciculus, corona radiata and in the posterior limb of the internal capsule. RD values followed a similar pattern, although decreased RD values in PKU patients were also found in the anterior limb of the internal capsule and in the cerebral peduncle. Decreased MD and RD values within the aforementioned regions had significant negative correlations with age, last year median and mean Phe and concurrent Phe values. No correlations were found with monoamines in urine or processing speed task. CONCLUSIONS: ETPKU patients showed MD and RD values significantly decreased across the whole brain when compared with HCs, and this damage was associated with high Phe values and the age of patients. Despite this microstructural damage, no affectation in processing speed was observed in patients with good metabolic control. DTI-MRI sequences could be used as a technique to quantify WM damage that is difficult to be detect in T1 or T2-weighted images, but also to quantify damage of WM through the follow up of patients with poor metabolic control in prospective studies.
format Online
Article
Text
id pubmed-6203973
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62039732018-11-01 White matter microstructural damage in early treated phenylketonuric patients González, María Julieta Polo, Mónica Rebollo Ripollés, Pablo Gassió, Rosa Ormazabal, Aída Sierra, Cristina Roura, Roser Colomé Artuch, Rafael Campistol, Jaume Orphanet J Rare Dis Research BACKGROUND: Despite dietary intervention, individuals with early treated phenylketonuria (ETPKU) could present neurocognitive deficits and white matter (WM) abnormalities. The aim of the present study was to evaluate the microstructural integrity of WM pathways across the whole brain in a cohort of paediatric ETPKU patients compared with healthy controls (HCs), by collecting DTI-MRI (diffusion tensor magnetic resonance imaging) data and diffusion values (mean diffusivity (MD), radial diffusivity (RD) and fractional anisotropy (FA)). METHODS: DTI-MRI data and diffusion values (MD, RD, FA) from WM tracts across the whole brain were analized using Tract Based Spatial Statistics (TBSS), in 15 paediatrics TPKU patients (median age: 12 years) and compared with 11 HCs. Areas showing abnormal values in the patient group were correlated (Pearson) with age, lifetime Phe values, last year median and mean Phe, concurrent Phe values in plasma, urine neurotransmitters status biomarkers, and with a processing speed task. RESULTS: ETPKU showed bilaterally decreased MD values compared with HCs in the body and splenium of the corpus callosum, superior longitudinal fasciculus, corona radiata and in the posterior limb of the internal capsule. RD values followed a similar pattern, although decreased RD values in PKU patients were also found in the anterior limb of the internal capsule and in the cerebral peduncle. Decreased MD and RD values within the aforementioned regions had significant negative correlations with age, last year median and mean Phe and concurrent Phe values. No correlations were found with monoamines in urine or processing speed task. CONCLUSIONS: ETPKU patients showed MD and RD values significantly decreased across the whole brain when compared with HCs, and this damage was associated with high Phe values and the age of patients. Despite this microstructural damage, no affectation in processing speed was observed in patients with good metabolic control. DTI-MRI sequences could be used as a technique to quantify WM damage that is difficult to be detect in T1 or T2-weighted images, but also to quantify damage of WM through the follow up of patients with poor metabolic control in prospective studies. BioMed Central 2018-10-26 /pmc/articles/PMC6203973/ /pubmed/30367646 http://dx.doi.org/10.1186/s13023-018-0912-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
González, María Julieta
Polo, Mónica Rebollo
Ripollés, Pablo
Gassió, Rosa
Ormazabal, Aída
Sierra, Cristina
Roura, Roser Colomé
Artuch, Rafael
Campistol, Jaume
White matter microstructural damage in early treated phenylketonuric patients
title White matter microstructural damage in early treated phenylketonuric patients
title_full White matter microstructural damage in early treated phenylketonuric patients
title_fullStr White matter microstructural damage in early treated phenylketonuric patients
title_full_unstemmed White matter microstructural damage in early treated phenylketonuric patients
title_short White matter microstructural damage in early treated phenylketonuric patients
title_sort white matter microstructural damage in early treated phenylketonuric patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203973/
https://www.ncbi.nlm.nih.gov/pubmed/30367646
http://dx.doi.org/10.1186/s13023-018-0912-5
work_keys_str_mv AT gonzalezmariajulieta whitemattermicrostructuraldamageinearlytreatedphenylketonuricpatients
AT polomonicarebollo whitemattermicrostructuraldamageinearlytreatedphenylketonuricpatients
AT ripollespablo whitemattermicrostructuraldamageinearlytreatedphenylketonuricpatients
AT gassiorosa whitemattermicrostructuraldamageinearlytreatedphenylketonuricpatients
AT ormazabalaida whitemattermicrostructuraldamageinearlytreatedphenylketonuricpatients
AT sierracristina whitemattermicrostructuraldamageinearlytreatedphenylketonuricpatients
AT rourarosercolome whitemattermicrostructuraldamageinearlytreatedphenylketonuricpatients
AT artuchrafael whitemattermicrostructuraldamageinearlytreatedphenylketonuricpatients
AT campistoljaume whitemattermicrostructuraldamageinearlytreatedphenylketonuricpatients